Inter-genotypic recombinant hepatitis C virus strains in Japan noted by discrepancies between immunoassay and sequencing

Journal of Medical Virology

Volumn 84, Issue 7, 2012, Pages 1018-1024

  Hoshino, Hiromi ^a   Hino, Kunihiko ^a   Miyakawa, Hiroshi ^b   Takahashi, Kazuaki ^c   Akbar, Sheikh Mohammad Fazle ^c   Mishiro, Shunji ^c  

^a Delta Clinic   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c Shinagawa ku   (Japan)

Author keywords

Genotype; HCV recombination; Japan; Serogroup

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; PRIMER DNA; RECOMBINANT INTERFERON;

AGED; ANTIVIRAL THERAPY; ARTICLE; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC RECOMBINATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INTERGENOTYPIC RECOMBINANT HEPATITIS C VIRUS; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEROTYPE; VIRUS ISOLATION; VIRUS RECOMBINANT;

AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOASSAY; JAPAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84860990341     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23300     Document Type: Article

References (23)

1. Chambers TJ, Fan X, Droll DA, Hembrador E, Slater T, Nickells MW, Dustin LB, Dibisceglie AM. 2005. Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol 79: 3071-3083.
2. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Wiener AJ, Bradley DW, Kuo G, Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88: 2451-2455.
3. Chung H, Ueda T, Kudo M. 2010. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 53: 39-43.
4. Colina R, Casane D, Vasquez S, Garcia-Aguirre L, Chunga A, Romero H, Khan B, Cristina J. 2004. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 85: 31-37.
5. Di Bisceglie AM, Hoofnagle JH. 2002. Optimal therapy of hepatitis C. Hepatology 36: S121-S127.
6. Dixit V, Quan S, Martin P, Larson D, Brezina M, DiNello R, Sra K, Lau JYN, Chien D, Kolberg J, Tagger A, Davis G, Polito A, Gitnick G. 1995. Evaluation of a novel serotyping system for hepatitis C virus: Strong correlation with standard genotyping methodologies. J Clin Microbiol 33: 2978-2983.
7. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to A natural recombinant hepatitis C virus in Japan interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334: 77-81.
8. Farci P, Strazzera R, Alter HJ, Farci S, Degioannis D, Coiana A, Peddis G, Usai F, Serra G, Chessa L, Diaz G, Balestrieri A, Purcell RH. 2002. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci USA 99: 3081-3086.
9. Gao F, Nainan OV, Khudyakov Y, Li J, Hong Y, Gonzales AC, Spelbring J, Margolis HS. 2007. Recombinant hepatitis C virus in experimentally infected chimpanzees. J Gen Virol 88: 143-147.
10. Ghany MG, Strader DB, Thomas DL, Seeff LB. 2009. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 49: 1335-1374.
11. Holmes EC, Worobey M, Rambaut A. 1999. Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol 16: 405-409.
12. Hoshino H, Hino K, Miyakawa Y, Takahashi K, Mishiro S. 2010. A novel 2b/1b recombinant HCV found in a case with discrepancy between serotype and genotype assessed by conventional methods. Kanzo (Japanese) 51: 319-321.
13. Kageyama S, Agdamag DM, Alesna ET, Leanõ PS, Heredia AM, Abellanosa-Tac-An IP, Jereza LD, Tanimoto T, Yamamura J, Ichimura H. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 8: 1423-1428.
14. Kalinina O, Norder H, Mukomolov S, Magnius LO. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76: 4034-4043.
15. Moradpour D, Penin F, Rice CM. 2007. Replication of hepatitis C virus. Nat Rev Microbiol 5: 453-463.
16. Morel V, Fournier C, Francois C, Brochot E, Helle F, Duverlie G, Castelain S. 2011. Genetic recombination of the hepatitis C virus: Clinical implications. J Viral Hepat 18: 77-83.
17. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282: 103-107.
18. Ogata N, Alter HJ, Miller RH, Purcell RH. 1991. Nucleotide sequence and mutation rate of H strain of hepatitis C virus. Proc Natl Acad Sci USA 88: 3392-3396.
19. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S. 1992. Genetic drift of hepatitis C virus during a 8.2-year infection in a Chimpanzee: Variability and stability. Virology 190: 894-899.
20. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002. 36: S35-S46.
21. Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, Ichijo T, Yoshizawa K, Kiyosawa K, Tanaka E. 2008. Nagano Interferon Treatment Research Group. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology 48: 1753-1760.
22. Takahashi K, Okamoto H, Abe N, Kawakami M, Matsuda H, Mochida S, Sakugawa H, Suginoshita Y, Watanabe S, Yamamoto K, Miyakawa Y, Mishiro S. 2009. Virulent strain of hepatitis E virus genotype 3, Japan. Emerg Infect Dis 15: 704-709.
23. Yokoyama K, Takahashi M, Nishizawa T, Nagashima S, Jirintai S, Yotsumoto S, Okamoto H, Momoi MY. 2011. Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan. Arch Virol 156: 1591-1601.